Molecular dynamics of substrate complexes with hamster cytochrome P450c17 (CYP17): mechanistic approach to understanding substrate binding and activities.

The cytochrome P450c17 isoforms from various animal species have different substrate selectivity, especially for 17,20-lyase activity. In particular, the human P450c17 selectively produces dehydroepiandrosterone with little androstenedione (AD). Hamster P450c17, on the other hand, produces both of these steroids at comparable rates. We thus investigated if computational analysis could explain the difference in activity profiles. Therefore, we inserted the four P450c17 substrates-pregnenolone, progesterone, and their 17alpha-hydroxylated forms-inside our hamster P450c17 model, which we derived from our human P450c17 model based on the crystal structure of P450BMP. We performed molecular dynamics (MD) simulations on the complexes and analyzed the resultant trajectories to identify amino acids that interact with substrates. Starting with substrates in two different orientations, we obtained two sets of binding trajectories in each case. The first set of trajectories reveal structural rearrangements that occur during binding, whereas the second set of trajectories reflects substrate orientations during catalysis. Our modeling suggests that three distinct steps are required for substrate selectivity and binding to the hamster P450c17: (1) recognition of the substrate at the putative substrate entrance, characterized by a pocket at the surface of the hamster P450c17 containing charged residues R96 and D116; (2) entry of the substrate into the active site, in an intermediate position directed by possible hydrogen bonding of the substrates with the heme D-ring propionate group, R96, R440, and T306; followed by (3) 90 degrees counterclockwise rotation of the substrates, positioning them in optimal position for reactivity, a process that may be directed by hydrogen bonding to the 110-112 region of the hamster P450c17. With some substrates, we obtained trajectories which suggest that major distortions in the I-helix and opening of the H-I loop occur during substrate binding. In conclusion, these modeling exercises provide insight to possible structural reorganizations that occur during substrate binding and suggest that amino acids that participate in three distinct steps of this process may all contribute to substrate binding and activity.

[1]  R. Auchus,et al.  Comparison of the hamster and human adrenal P450c17 (17α-hydroxylase/17,20-lyase) using site-directed mutagenesis and molecular modeling , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  K. Jones,et al.  Missense mutation serine106----proline causes 17 alpha-hydroxylase deficiency. , 1991, The Journal of biological chemistry.

[3]  J Deisenhofer,et al.  Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. , 1993, Science.

[4]  M. Akhtar,et al.  An analysis of the role of active site protic residues of cytochrome P-450s: mechanistic and mutational studies on 17alpha-hydroxylase-17,20-lyase (P-45017alpha also CYP17). , 1998, The Biochemical journal.

[5]  M. Dufau,et al.  Rat testis P-45017α cDNA: The deduced amino acid sequence, expression and secondary structural configuration , 1988 .

[6]  J. Simard,et al.  Mutation R96W in cytochrome P450c17 gene causes combined 17 alpha-hydroxylase/17-20-lyase deficiency in two French Canadian patients. , 1996, Journal of Clinical Endocrinology and Metabolism.

[7]  D. Hum,et al.  Point mutation of Arg440 to His in cytochrome P450c17 causes severe 17 alpha-hydroxylase deficiency. , 1994, The Journal of clinical endocrinology and metabolism.

[8]  A. Fleury,et al.  Cloning and Expression of Hamster Adrenal Cytochrome P450C17 cDNA a , 1995, Annals of the New York Academy of Sciences.

[9]  M. Waterman,et al.  Rat P45017α from Testis: Characterization of a Full-Length cDNA Encoding a Unique Steroid Hydroxylase Capable of Catalyzing Both Δ4- and Δ5-Steroid-17,20-Lyase Reactions , 1989 .

[10]  M. Waterman,et al.  Expression and purification of functional human 17 alpha-hydroxylase/17,20-lyase (P450c17) in Escherichia coli. Use of this system for study of a novel form of combined 17 alpha-hydroxylase/17,20-lyase deficiency. , 1993, The Journal of biological chemistry.

[11]  M. Waterman,et al.  17α-Hydroxylase/17,20-Lyase Deficiency: From Clinical Investigation to Molecular Definition* , 1991 .

[12]  S. Neidle,et al.  Homology modelling of the enzyme P450 17 alpha-hydroxylase/17,20-lyase--a target for prostate cancer chemotherapy--from the crystal structure of P450BM-3. , 1997, Anti-cancer drug design.

[13]  J. Li,et al.  Characterization of specific glucocorticoid receptor in the Syrian hamster testis. , 1981, Endocrinology.

[14]  R. Auchus The genetics, pathophysiology, and management of human deficiencies of P450c17. , 2001, Endocrinology and metabolism clinics of North America.

[15]  W. Grizzle,et al.  Golden Syrian hamsters: a new experimental model for adrenal compensatory hypertrophy. , 1984, Endocrinology.

[16]  C. Sklar,et al.  Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. , 1980, The Journal of clinical endocrinology and metabolism.

[17]  L. Perkins,et al.  Quantification of P450scc, P45017α, and Iron Sulfur Protein Reductase in Leydig Cells and Adrenals of Inbred Strains of Mice , 1988 .

[18]  M. Waterman,et al.  Hormonal regulation of rat Leydig cell cytochrome P-45017α mRNA levels and characterization of a partial length rat P-45017α cDNA , 1988 .

[19]  T. Poulos,et al.  High-resolution crystal structure of cytochrome P450cam. , 1987, Journal of molecular biology.

[20]  E. Chiao,et al.  Modeling and mutagenesis of the active site of human P450c17. , 1994, Molecular endocrinology.

[21]  A. Fleury,et al.  Characterization of the adrenal cytochrome P450C17 in the hamster, a small animal model for the study of adrenal dehydroepiandrosterone biosynthesis. , 1997, DNA and cell biology.

[22]  P. Lee-Robichaud,et al.  Modulation of the activity of human 17 alpha-hydroxylase-17,20-lyase (CYP17) by cytochrome b5: endocrinological and mechanistic implications. , 1995, The Biochemical journal.

[23]  Conrad C. Huang,et al.  The MIDAS display system , 1988 .

[24]  R. Wade,et al.  Comparison of the dynamics of substrate access channels in three cytochrome P450s reveals different opening mechanisms and a novel functional role for a buried arginine , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Miller,et al.  Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer* , 1998, The Journal of Biological Chemistry.

[26]  Stephen Neidle,et al.  A molecular model for the enzyme cytochrome P45017α, a major target for the chemotherapy of prostatic cancer , 1990 .

[27]  B. Taylor,et al.  Isolation, characterization, and chromosomal mapping of mouse P450 17 alpha-hydroxylase/C17-20 lyase. , 1991, Genomics.

[28]  F. Schröder,et al.  Adrenal glands of mouse and rat do not synthesize androgens. , 1992, Life sciences.

[29]  W. Miller,et al.  Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations. , 1999, Molecular endocrinology.

[30]  W L Miller,et al.  Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.